The global PVC medical tubing market was valued at USD 2,780.0 million in 2025 and is projected to reach USD 4,222.04 million by 2032, at a CAGR of 6.15% over the period, according to PW Consulting. PVC medical tubing is a widely used healthcare material for IV sets, catheters, respiratory circuits, dialysis lines and fluid-delivery systems, combining clarity, flexibility and cost-effectiveness.

PVC medical tubing delivers excellent transparency for visual fluid inspection, kink resistance, flexibility and compatibility with sterilisation methods, making it a preferred choice for infusion and drainage applications across hospitals and clinical care. Demand is tied to the expansion of global healthcare infrastructure, rising surgical and critical-care procedures, and the growth of home-care and point-of-care treatment, alongside a sustained shift toward medical-grade formulations that meet biocompatibility and regulatory standards.

Asia-Pacific is the largest and fastest-growing region, supported by expanding hospital networks and medical-device manufacturing in China, India and Southeast Asia, with Europe and North America sustaining strong demand in high-value infusion and catheter applications. Continued healthcare investment positions PVC medical tubing as a structurally advancing application underpinning demand for medical-grade PVC compounds, plasticizers and stabilizers.